Global and regional patterns in cardiovascular mortality from 1990 to 2013

Circulation

Volumn 132, Issue 17, 2015, Pages 1667-1678

  Roth, Gregory A ^a   Huffman, Mark D ^b   Moran, Andrew E ^c   Feigin, Valery ^d   Mensah, George A ^e   Naghavi, Mohsen ^a   Murray, Christopher J L ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Cardiovascular diseases; Epidemiology; Global health; Mortality

Indexed keywords

AFRICA SOUTH OF THE SAHARA; AORTA ANEURYSM; ASIA; ATRIAL FIBRILLATION; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARIBBEAN; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIABETES MELLITUS; ENDOCARDITIS; HUMAN; ISCHEMIC HEART DISEASE; MIDDLE EAST; NORTH AFRICA; PERIPHERAL VASCULAR DISEASE; PHYSICAL ACTIVITY; PREMATURE MORTALITY; PRIORITY JOURNAL; REVIEW; RHEUMATIC HEART DISEASE; SOUTH AND CENTRAL AMERICA; ADULT; AGE DISTRIBUTION; AGED; DEVELOPED COUNTRY; DEVELOPING COUNTRY; FEMALE; FORECASTING; HEALTH; INCOME; INFORMATION PROCESSING; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; SEX RATIO; TRENDS;

ADULT; AGE DISTRIBUTION; AGED; CARDIOVASCULAR DISEASES; DATA COLLECTION; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; FEMALE; FORECASTING; GLOBAL HEALTH; HUMANS; INCOME; MALE; MIDDLE AGED; MORTALITY; MORTALITY, PREMATURE; RETROSPECTIVE STUDIES; RHEUMATIC HEART DISEASE; SEX DISTRIBUTION;

EID: 84945957413     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.008720     Document Type: Review

References (56)

1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specifc all-cause and cause-specifc mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117-171.
2. Global action plan for the prevention and control of non-communicable diseases 2013-2020. Geneva, Switzerland: World Health Organization; 2013.
3. Roth GA, Forouzanfar MH, Moran AE, Barber R, Nguyen G, Feigin VL, Naghavi M, Mensah GA, Murray CJ. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015;372:1333-1341. doi: 10.1056/NEJMoa1406656.
4. Kim JY. Data for better health-and to help end poverty. Lancet. 2012;380:2055. doi: 10.1016/S0140-6736(12)62162-X.
5. Parikh NI, Gona P, Larson MG, Fox CS, Benjamin EJ, Murabito JM, O'Donnell CJ, Vasan RS, Levy D. Long-term trends in myocardial infarction incidence and case fatality in the National Heart, Lung, and Blood Institute's Framingham Heart study. Circulation. 2009;119:1203-1210. doi: 10.1161/CIRCULATIONAHA.108.825364.
6. The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects). Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet. 2014;383:970-983.
7. Keys A (ed). Coronary heart disease in seven countries. Circulation. 1970;41:1-211.
8. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet. 1999;353:1547-1557.
9. Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, Gupta R, Kelishadi R, Iqbal R, Avezum A, Kruger A, Kutty R, Lanas F, Lisheng L, Wei L, Lopez-Jaramillo P, Oguz A, Rahman O, Swidan H, Yusoff K, Zatonski W, Rosengren A, Teo KK; Prospective Urban Rural Epidemiology (PURE) Study Investigators. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet. 2011;378:1231-1243. doi: 10.1016/S0140-6736(11)61215-4.
10. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-952. doi: 10.1016/S0140-6736(04)17018-9.
11. Foreman KJ, Lozano R, Lopez AD, Murray CJ. Modeling causes of death: an integrated approach using CODEm. Popul Health Metr. 2012;10:1. doi: 10.1186/1478-7954-10-1.
12. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ. Worldwide epidemiology of atrial fbrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837-847. doi: 10.1161/CIRCULATIONAHA.113.005119.
13. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UK, Williams LJ, Mensah GA, Criqui MH. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329-1340. doi: 10.1016/S0140-6736(13)61249-0.
14. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356:2388-2398. doi: 10.1056/NEJMsa053935.
15. Ikeda N, Sapienza D, Guerrero R, Aekplakorn W, Naghavi M, Mokdad AH, Lozano R, Murray CJ, Lim SS. Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. Bull World Health Organ. 2014;92:10-19C. doi: 10.2471/BLT.13.121954.
16. Roth GA, Fihn SD, Mokdad AH, Aekplakorn W, Hasegawa T, Lim SS. High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries. Bull World Health Organ. 2011;89:92-101. doi: 10.2471/BLT.10.079947.
17. Epstein FH. The relationship of lifestyle to international trends in CHD. Int J Epidemiol. 1989;18(3 suppl 1):S203-S209.
18. Marmot MG. Life style and national and international trends in coronary heart disease mortality. Postgrad Med J. 1984;60:3-8.
19. Stamler J. The marked decline in coronary heart disease mortality rates in the United States, 1968-1981; summary of fndings and possible explanations. Cardiology. 1985;72:11-22.
20. Ueshima H. Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke. J Atheroscler Thromb. 2007;14:278-286.
21. Woolf SH, Aron, eds; Panel on Understanding Cross-National Health Differences Among High-Income Countries; Committee on Population; Division of Behavioral and Social Sciences and Education; National Research Council; Board on Population Health and Public Health Practice; Institute of Medicine. U.S. Health in International Perspective: Shorter Lives, Poorer Health. Washington, DC: National Academies Press; 2013.
22. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8:355-369. doi: 10.1016/S1474-4422(09)70025-0.
23. Hong Y, Bots ML, Pan X, Hofman A, Grobbee DE, Chen H. Stroke incidence and mortality in rural and urban Shanghai from 1984 through 1991. Findings from a community-based registry. Stroke. 1994;25:1165-1169.
24. Zaridze D, Brennan P, Boreham J, Boroda A, Karpov R, Lazarev A, Konobeevskaya I, Igitov V, Terechova T, Boffetta P, Peto R. Alcohol and cause-specifc mortality in Russia: a retrospective case-control study of 48, 557 adult deaths. Lancet. 2009;373:2201-2214. doi: 10.1016/S0140-6736(09)61034-5.
25. Shkolnikov V, Andreev EM, McKee M, Leon DA. Components and possible determinants of decrease in Russian mortality in 2004-2010. Demographic Res. 2013;28:917-950.
26. Kesteloot H, Sans S, Kromhout D. Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. Eur Heart J. 2006;27:107-113. doi: 10.1093/eurheartj/ehi511.
27. Curioni C, Cunha CB, Veras RP, André C. The decline in mortality from circulatory diseases in Brazil. Rev Panam Salud Publica. 2009;25:9-15.
28. Da Costa e Silva VL, Koifman S. Smoking in Latin America: a major public health problem. Cad Saude Publica. 1998;14 Suppl 3: 99-108.
29. Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S, Yusuf S; INTERHEART Investigators in Latin America. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation. 2007;115:1067-1074. doi: 10.1161/CIRCULATIONAHA.106.633552.
30. Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, Wollum A, Sanman E, Wulf S, Lopez AD, Murray CJ, Gakidou E. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA. 2014;311:183-192. doi: 10.1001/jama.2013.284692.
31. Ahern RM, Lozano R, Naghavi M, Foreman K, Gakidou E, Murray CJ. Improving the public health utility of global cardiovascular mortality data: the rise of ischemic heart disease. Popul Health Metr. 2011;9:8. doi: 10.1186/1478-7954-9-8.
32. Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis. 2009;49:e52-e54. doi: 10.1086/605091.
33. Forouzanfar MH, Moran A, Phillips D, Mensah G, Ezzati M, Naghavi M, Murray CJ. Prevalence Of Heart Failure By Cause In 21 Regions: Global Burden Of Diseases, Injuries And Risk Factors-2010 Study. J Am Coll Cardiol. 2013;61:E786.
34. Jha P, Gajalakshmi V, Gupta PC, Kumar R, Mony P, Dhingra N, Peto R; RGI-CGHR Prospective Study Collaborators. Prospective study of one million deaths in India: rationale, design, and validation results. PLoS Med. 2006;3:e18. doi: 10.1371/journal.pmed.0030018.
35. Goyal A, Yusuf S. The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res. 2006;124:235-244.
36. Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, Bo J, Lou Q, Lu F, Liu T, Yu L, Zhang S, Mony P, Swaminathan S, Mohan V, Gupta R, Kumar R, Vijayakumar K, Lear S, Anand S, Wielgosz A, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Yusoff K, Ismail N, Iqbal R, Rahman O, Rosengren A, Yusufali A, Kelishadi R, Kruger A, Puoane T, Szuba A, Chifamba J, Oguz A, McQueen M, McKee M, Dagenais G; PURE Investigators. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. 2014;371:818-827. doi: 10.1056/NEJMoa1311890.
37. Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012;70:3-21. doi: 10.1111/j.1753-4887.2011.00456.x.
38. Maziak W. The global epidemic of waterpipe smoking. Addict Behav. 2011;36:1-5. doi: 10.1016/j.addbeh.2010.08.030.
39. Rahim HF, Sibai A, Khader Y, Hwalla N, Fadhil I, Alsiyabi H, Mataria A, Mendis S, Mokdad AH, Husseini A. Non-communicable diseases in the Arab world. Lancet. 2014;383:356-367. doi: 10.1016/S0140-6736(13)62383-1.
40. Mensah GA, Roth GA, Sampson UK, Moran AE, Feigin VL, Forouzanfar MH, Naghavi M, Murray CJ, GBD 2013 Mortality and Causes of Death collaborators. Mortality from cardiovascular diseases in sub-Saharan Africa, 1990-2013: a systematic analysis of data from the Global Burden of Disease Study 2013. Cardiovasc J Afr. 2015;26:S6-S10.
41. Mensah GA. Descriptive epidemiology of cardiovascular risk factors and diabetes in sub-Saharan Africa. Prog Cardiovasc Dis. 2013;56:240-250. doi: 10.1016/j.pcad.2013.10.014.
42. Moran A, Forouzanfar M, Sampson U, Chugh S, Feigin V, Mensah G. The epidemiology of cardiovascular diseases in sub-Saharan Africa: the Global Burden of Diseases, Injuries and Risk Factors 2010 Study. Prog Cardiovasc Dis. 2013;56:234-239. doi: 10.1016/j.pcad.2013.09.019.
43. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:685-694. doi: 10.1016/S1473-3099(05)70267-X.
44. Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971;49:509-538.
45. Schultz TW. Food for the World. Chicago, IL: University of Chicago Press; 1945.
46. Olshansky SJ, Ault AB. The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. Milbank Q. 1986;64:355-391.
47. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746-2753.
48. Lang T, Rayner G. Ecological public health: the 21st century's big idea? An essay by Tim Lang and Geof Rayner. BMJ. 2012;345:e5466.
49. Mirzaei M, Truswell AS, Taylor R, Leeder SR. Coronary heart disease epidemics: not all the same. Heart. 2009;95:740-746. doi: 10.1136/hrt.2008.154856.
50. Balabanova D, Mills A, Conteh L, Akkazieva B, Banteyerga H, Dash U, Gilson L, Harmer A, Ibraimova A, Islam Z, Kidanu A, Koehlmoos TP, Limwattananon S, Muraleedharan VR, Murzalieva G, Palafox B, Panichkriangkrai W, Patcharanarumol W, Penn-Kekana L, Powell-Jackson T, Tangcharoensathien V, McKee M. Good health at low cost 25 years on: lessons for the future of health systems strengthening. Lancet. 2013;381:2118-2133. doi: 10.1016/S0140-6736(12)62000-5.
51. Boutayeb A. The double burden of communicable and non-communicable diseases in developing countries. Trans R Soc Trop Med Hyg. 2006;100:191-199. doi: 10.1016/j.trstmh.2005.07.021.
52. Ezzati M, Vander Hoorn S, Lawes CM, Leach R, James WP, Lopez AD, Rodgers A, Murray CJ. Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med. 2005;2:e133. doi: 10.1371/journal. pmed.0020133.
53. Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D. The burden of non-communicable diseases in South Africa. Lancet. 2009;374:934-947. doi: 10.1016/S0140-6736(09)61087-4.
54. Cochrane AL, Fellowship RC. Effectiveness and Effciency: Random Refections on Health Services. London, UK: Nuffeld Provincial Hospitals Trust London; 1972.
55. Chan M. From new estimates to better data. Lancet. 2012;380:2054. doi: 10.1016/S0140-6736(12)62135-7.
56. Huffman MD, Rao KD, Pichon-Riviere A, Zhao D, Harikrishnan S, Ramaiya K, Ajay VS, Goenka S, Calcagno JI, Caporale JE, Niu S, Li Y, Liu J, Thankappan KR, Daivadanam M, van Esch J, Murphy A, Moran AE, Gaziano TA, Suhrcke M, Reddy KS, Leeder S, Prabhakaran D. A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low-and middle-income countries. PLoS One. 2011;6:e20821. doi: 10.1371/journal.pone.0020821.